These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
¨
|
|
Preliminary Proxy Statement
|
¨
|
|
Confidential, for use of the Commission only (as permitted by Rule 14a-6(e)(2))
|
x
|
|
Definitive Proxy Statement
|
¨
|
|
Definitive Additional Materials
|
¨
|
|
Soliciting Material Pursuant to Section 240.14a-12
|
x
|
No fee required.
|
¨
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
(1)
|
Title of each class of securities to which transaction applies:
|
(2)
|
Aggregate number of securities to which transaction applies:
|
(3)
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
(4)
|
Proposed maximum aggregate value of transaction:
|
(5)
|
Total fee paid:
|
¨
|
Fee paid previously with preliminary materials.
|
¨
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
|
(1)
|
Amount Previously Paid:
|
(2)
|
Form, Schedule or Registration Statement No.:
|
(3)
|
Filing Party:
|
(4)
|
Date Filed:
|
1.
|
The election of seven directors to serve until the next annual meeting of stockholders of the Company or until their successors are duly elected and qualified, or until their earlier resignation or removal.
|
2.
|
The approval of the Amended and Restated Flotek Industries, Inc. 2014 Long-Term Incentive Plan.
|
3.
|
The approval of a non-binding advisory vote on executive compensation.
|
4.
|
The ratification of the selection of the independent registered public accounting firm for the year ending
December 31, 2016
.
|
5.
|
Any other business which may be properly brought before the meeting or any adjournment thereof.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Name
|
|
Shares Owned
(a)
|
|
Right to
Acquire (b) |
|
Total Shares
|
|
Percent of
Class (c) |
|||
Named Executive Officers and Directors
|
|
|
|
|
|
|
|
|
|||
John W. Chisholm
|
|
891,880
|
|
|
400,000
|
|
|
1,291,880
|
|
|
2.36%
|
Steven A. Reeves
(d) (e)
|
|
267,514
|
|
|
200,000
|
|
|
467,514
|
|
|
*
|
Joshua A. Snively, Sr.
(f)
|
|
316,119
|
|
|
—
|
|
|
316,119
|
|
|
*
|
Robert M. Schmitz
|
|
83,327
|
|
|
—
|
|
|
83,327
|
|
|
*
|
H. Richard Walton
|
|
174,167
|
|
|
—
|
|
|
174,167
|
|
|
*
|
Kenneth T. Hern
|
|
77,674
|
|
|
9,047
|
|
|
86,721
|
|
|
*
|
John S. Reiland
|
|
40,382
|
|
|
9,047
|
|
|
49,429
|
|
|
*
|
L.V. “Bud” McGuire
|
|
99,010
|
|
|
9,047
|
|
|
108,057
|
|
|
*
|
L. Melvin Cooper
|
|
63,316
|
|
|
37,618
|
|
|
100,934
|
|
|
*
|
Carla S. Hardy
(g)
|
|
394,976
|
|
|
—
|
|
|
394,976
|
|
|
*
|
Ted D. Brown
|
|
18,774
|
|
|
—
|
|
|
18,774
|
|
|
*
|
All executive officers and directors as a group (11 persons)
|
|
2,427,139
|
|
|
664,759
|
|
|
3,091,898
|
|
|
5.64%
|
5% Beneficial Owners
|
|
|
|
|
|
|
|
|
|||
T. Rowe Price Associates, Inc.
(h)
|
|
6,188,951
|
|
|
—
|
|
|
6,188,951
|
|
|
11.28%
|
Gates Capital Management, Inc.
(i)
|
|
7,466,931
|
|
|
—
|
|
|
7,466,931
|
|
|
13.61%
|
BlackRock, Inc.
(j)
|
|
5,045,569
|
|
|
—
|
|
|
5,045,569
|
|
|
9.20%
|
The Vanguard Group
(k)
|
|
3,928,766
|
|
|
—
|
|
|
3,928,766
|
|
|
7.16%
|
Millennium Management LLC
(l)
|
|
4,106,420
|
|
|
—
|
|
|
4,106,420
|
|
|
7.49%
|
(a)
|
Except as otherwise disclosed, the persons named in the table have sole voting and investment power of all shares of Common Stock which are beneficially owned by them. Includes the following number of unvested shares of restricted stock for the persons indicated: Mr. Chisholm -
251,084
; Mr. Reeves -
77,886
; Mr. Snively, Sr. -
70,851
; Mr. Schmitz -
51,941
;Mr. Walton -
64,565
; Mr. Hern -
8,535
; Mr. Reiland -
8,535
; Mr. McGuire -
8,535
; Mr.Cooper -
8,535
; Ms. Hardy -
8,535
; and Mr. Brown -
8,535
. None of the named executive officers or directors have pledged shares.
|
(b)
|
Shares subject to options granted pursuant to the Company’s incentive plans and exercisable within 60 days of
March 3, 2016
. This assumes that all options beneficially owned by the person are exercised for shares of Common Stock.
|
(c)
|
Based on an aggregate of
54,847,737
shares of Common Stock outstanding and entitled to vote as of
March 3, 2016
.
|
(d)
|
Includes shares previously acquired through the Company’s 401(k) Plan.
|
(e)
|
Mr. Reeves’ holdings include
120,992
shares of Common Stock held in trust, for which Mr. Reeves is a trustee and beneficiary.
|
(f)
|
Mr. Snively’s holdings include
114,345
shares of Common Stock held in trust, for which Mr. Snively is a trustee and beneficiary, and
128,916
shares of Common Stock held in trust, for which Mr. Snively’s spouse is a trustee and beneficiary.
|
(g)
|
Ms. Hardy’s holdings include
182,040
shares of Common Stock held in trust, for which Ms. Hardy is a trustee and beneficiary, and
200,021
shares of Common Stock held in trusts for which members of Ms. Hardy’s immediate family are beneficiaries.
|
(h)
|
The address of T. Rowe Price Associates, Inc. is 100 E. Pratt Street, Baltimore, MD 21202. These securities are owned by various individual and institutional investors which T. Rowe Price Associates, Inc. (“Price Associates”) serves as an investment adviser with power to direct investment and/or sole power to vote the securities. For the purposes of the reporting requirements of the Securities Exchange Act of 1934, Price Associates is deemed to be a beneficial owner of such securities; however, Price Associates expressly disclaims that it is, in fact, the beneficial owner of such securities. Ownership information originated from the Schedule 13G/A filed with the Securities and Exchange Commission by Price Associates on February 11, 2016.
|
(i)
|
The address of Gates Capital Management, Inc. (“Gates”) is 1177 Avenue of Americas, 46th Floor, New York, NY 10036. Gates Capital Management, Inc., which is controlled by Jeffrey L. Gates, is the managing member of Gates Capital Management GP, LLC, which is the general partner of Gates Capital Management, LP., which is the investment manager of certain Gates Capital Funds. Jeffrey L. Gates exercises voting and dispositive power over the securities held by each of the funds listed above (collectively, the “Funds”). Gates may be deemed to be the beneficial owner of the securities held by the Funds, although all reported securities are owned by the Funds. Ownership information originated from the Schedule 13G/A filed with the Securities and Exchange Commission by Gates on February 10, 2016.
|
(j)
|
The address of BlackRock, Inc. is 55 East 52nd Street, New York, NY 10055. Spencer Fleming exercises voting and dispositive power over the securities held by BlackRock, Inc. Ownership information originated from the Schedule 13G/A filed with the Securities and Exchange Commission by BlackRock, Inc. on January 26, 2016.
|
(k)
|
The address of The Vanguard Group is 100 Vanguard Blvd., Malvern, PA 19355. Ownership information originated from the Schedule 13G/A filed with the Securities and Exchange Commission by The Vanguard Group on February 10, 2016.
|
(l)
|
The address of Millennium Management LLC is 666 Fifth Avenue, New York, NY 10103. Israel A. Englander is the managing member of Millennium International Management GP LLC, which is the general partner of Millennium International Management, which is the investment manager to Integrated Assets, Ltd., and Millennium Management LLC, which is the general partner of the managing member of Integrated Core Strategies (US) LLC. Israel A. Englander exercises voting and dispositive power over the securities held by each of the funds listed above (collectively, the “Funds”). Ownership information originated from the Schedule 13G/A filed with the Securities and Exchange Commission by Millennium Management LLC on January 15, 2016.
|
Name and Age
|
|
Positions
|
|
Position
Held Since
|
John W. Chisholm (61)
|
|
Chief Executive Officer
|
|
2012
|
|
|
President and Chairman of the Board
|
|
2010
|
|
|
Interim President
|
|
2009
|
|
|
|
|
|
Steven A. Reeves (65)
|
|
Executive Vice President, Operations
|
|
2011
|
|
|
Executive Vice President, Operations, Business Development and Special Projects
|
|
2010
|
|
|
Executive Vice President, Business Development and Special Projects
|
|
2009
|
|
|
Executive Vice President and Chief Operating Officer
|
|
2008
|
|
|
President Downhole Tool Division
|
|
2007
|
|
|
|
|
|
Joshua A. Snively, Sr. (51)
|
|
Executive Vice President, Research and Innovation
|
|
2013
|
|
|
President of Florida Chemical Company, Inc., a wholly-owned subsidiary of the Company
|
|
2013
|
|
|
|
|
|
Robert M. Schmitz (61)
|
|
Executive Vice President and Chief Financial Officer
|
|
2015
|
|
|
|
|
|
H. Richard Walton (67)
|
|
Chief Financial Officer Emeritus
|
|
2015
|
|
|
Executive Vice President and Chief Financial Officer
|
|
2013
|
|
|
Chief Financial Officer (Interim)
|
|
2013
|
|
|
|
|
|
•
|
The Company reported revenue for the year ended December 31, 2015 of $334.4 million, a decrease of $114.8 million, or 25.6%, compared to $449.2 million for the year ended December 31, 2014. The decline in revenue, however, was not as drastic as the 47.8% decline in average North American active rig count during the same period.
|
•
|
During the second quarter of 2015, as a result of decreased rig activity and its impact on management’s
|
•
|
The Company reported a net loss, including the impairment charge discussed above, for the year ended December 31, 2015 of $13.5 million, or $0.25 per share (fully diluted), compared to net income of $53.6 million, or $0.97 per share (fully diluted), for the year ended December 31, 2014.
|
•
|
The Company is successfully expanding into foreign markets. Revenue from services and products used in foreign countries increased to 18.2% of consolidated revenue in 2015 compared to 13.9% of consolidated revenue in 2013.
|
•
|
The Company continues to emphasize and expand its research and innovation activities. These activities focus on improvement of existing products and services, the design of reservoir specific, customized chemistries, and the development of new products, processes, and services. Research and innovation expense increased to $7.5 million in 2015 compared to $3.8 million in 2013.
|
•
|
During 2015, the Company continued to promote the efficacy of its CnF
®
chemistries resulting in an 18.0% increase in CnF
®
sales volumes compared to 2014. CnF
®
volumes continued to increase throughout the year with the fourth quarter of 2015 having the highest quarterly volume of CnF
®
sales on record. The Company achieved this growth despite a 47.8% annual decline in general oilfield activity as measured by active rig count.
|
•
|
During 2014, the Company acquired a company that is a leading Enhanced Oil Recovery design and injection firm and a company that provides reservoir engineering and modeling services for a variety of hydrocarbon applications. These acquisitions fit with the Company’s existing products and services and provide an opportunity to expand the Company’s customer base. In early 2015, the Company acquired the assets of a business that will allow the Company to control the manufacturing and service quality of next-generation hydraulic pumping units.
|
•
|
A thorough review of compensation strategies and objectives;
|
•
|
A review of and recommended changes to the Chief Executive Officer’s employment agreement and other executive employment agreements, including adoption of “double-trigger” cash severance and equity acceleration following a change-in-control;
|
•
|
Adoption of a claw-back policy;
|
•
|
A review of policies and recommended changes relating to prohibited hedging transactions and the prohibition of pledging Company securities;
|
•
|
Adoption of stock ownership guidelines for executives and directors;
|
•
|
A review and update of the Peer Group composition;
|
•
|
A restructuring and refinement of executive annual incentive compensation opportunities making amounts earned under the program primarily contingent on financial measures that drive shareholder returns;
|
•
|
Adoption of an annual equity-based long-term incentive component to total compensation based on the Company’s total shareholder return and the Company’s performance relative to a peer group; and
|
•
|
Extension of the performance period to two years for the equity-based long-term incentive component.
|
Name
|
|
Title
|
John W. Chisholm
(1)
|
|
Chairman of the Board, President and Chief Executive Officer
|
Steven A. Reeves
(2)
|
|
Executive Vice President, Operations
|
Joshua A. Snively, Sr.
(3)
|
|
Executive Vice President, Research and Innovation and President of Florida Chemical Co.
|
Robert M. Schmitz
(4)
|
|
Executive Vice President and Chief Financial Officer
|
H. Richard Walton
(5)
|
|
Chief Financial Officer Emeritus
|
(1)
|
Mr. Chisholm was appointed Interim President under the terms of a Service Agreement effective August 11, 2009, and became President on August 12, 2010. Mr. Chisholm was elected Chairman of the Board on July 13, 2010. Mr. Chisholm was appointed Chief Executive Officer effective March 5, 2012.
|
(2)
|
Mr. Reeves was appointed Executive Vice President, Operations effective May 19, 2011. He previously served as Executive Vice President, Operations, Business Development and Special Projects, Executive Vice President, Business Development and Special Projects, and Executive Vice President and Chief Operating Officer.
|
(3)
|
Mr. Snively was appointed President of Florida Chemical Company, Inc. effective May 10, 2013 and was appointed Executive Vice President, Research and Innovation, effective November 4, 2013.
|
(4)
|
Mr. Schmitz was appointed Executive Vice President and Chief Financial Officer effective May 1, 2015.
|
(5)
|
Mr. Walton was appointed Chief Financial Officer Emeritus effective May 29, 2015. He previously served as Executive Vice President and Chief Financial Officer.
|
•
|
Compensation Committee chaired by an independent non-employee director. All Compensation Committee members are independent;
|
•
|
Representation from the Audit Committee on the Compensation Committee;
|
•
|
Review of executive compensation programs by the Compensation Committee’s independent compensation consultant;
|
•
|
Robust review of compensation program elements and key performance drivers; and
|
•
|
Detailed measurement of short- and long-term compensation elements to ensure balance.
|
•
|
The Company has strong internal financial controls that are assessed annually by the Company’s independent public accountants, in addition to their audits of the Company’s financial statements.
|
•
|
Base salaries are generally consistent with market practice and the employees’ responsibilities, so employees are not motivated to take excessive risks to attain a reasonable level of financial security.
|
•
|
The determination of incentive awards is based on well-defined financial measures. There is a maximum incentive opportunity for each named executive officer, and the Committee retains discretion to adjust bonuses to eliminate anomalous or inappropriate outcomes.
|
•
|
Long-term incentives are designed to provide appropriate awards for successful outcomes, and effectively align realized compensation with returns realized by investors.
|
•
|
Since December 31, 2012, the Company has had a claw-back policy that covers executive officers and other officers who participate in the Company’s incentive plans. This policy permits the Company to recover incentive compensation awarded or paid if there is a subsequent change to a performance measure and in instances where an officer engaged in intentional misconduct.
|
•
|
All officers and directors are prohibited from purchasing or selling Company securities while in possession of material, non-public information. All officers and directors must pre-clear any transactions involving Flotek common stock with the Company’s Compliance Officer.
|
•
|
In 2014, the Company clarified its Insider Trading Policy with respect to its hedging policy and its pledging policy. Hedging transactions are prohibited, and the pledging of Company securities to secure indebtedness is prohibited.
|
•
|
The Company has established formal stock ownership guidelines. These guidelines, based on a multiple of base salary for executive officers and on the annual cash retainer for directors, help ensure that their interests are aligned with those of our stockholders.
|
•
|
The Company has a Code of Business Conduct and Ethics. This Code requires each employee and director to sign a Compliance Certification. In addition, employees are required to complete annual anti-bribery training.
|
•
|
Attract and retain talented and experienced executives with the skills necessary to run and grow our existing business segments;
|
•
|
Align the interests of our executive officers with those of stockholders to increase the value of our enterprise;
|
•
|
Motivate and reward executives whose knowledge, skills, and performance are critical to our success;
|
•
|
Demonstrate fairness among the executive management team by recognizing the contributions each executive makes to our success;
|
•
|
Provide that executives are accountable to the Board for their performance; and
|
•
|
Encourage a shared commitment among executives by coordinating Company and individual business unit targets, goals, and objectives.
|
Basic Energy Services, Inc.
|
|
Newpark Resources, Inc.
|
CARBO Ceramics Inc.
|
|
Parker Drilling Company
|
C&J Energy Services, Inc.
|
|
RPC, Inc.
|
Key Energy Services, Inc.
|
|
Tesco Corporation
|
Layne Christensen Company
|
|
TETRA Technologies, Inc.
|
Matrix Service Company
|
|
|
Role
|
|
Guideline
|
Chief Executive Officer
|
|
6 times base salary
|
Other executive officers
|
|
2 times base salary
|
Directors
|
|
5 times annual retainer
|
•
|
Base salary;
|
•
|
Annual incentive opportunity; and
|
•
|
Equity compensation under the long-term incentive plans.
|
Name
|
|
Base Salary
|
|
Annual Incentive
at Target Amount
|
|
Long-Term Incentive at Target Value
|
|
Total
|
John W. Chisholm
|
|
17.4%
|
|
17.4%
|
|
65.2%
|
|
100%
|
Steven A. Reeves
|
|
26.7%
|
|
20.0%
|
|
53.3%
|
|
100%
|
Joshua A. Snively, Sr.
|
|
28.6%
|
|
17.1%
|
|
54.3%
|
|
100%
|
Robert M. Schmitz
|
|
27.0%
|
|
18.9%
|
|
54.1%
|
|
100%
|
H. Richard Walton
|
|
27.0%
|
|
18.9%
|
|
54.1%
|
|
100%
|
Name
|
|
Title
|
|
Beginning
Salary
|
|
New Salary
|
|
Percent Increase
|
Steven A. Reeves
|
|
EVP, Operations
|
|
$418,000
|
|
$435,000
|
|
4.07%
|
Joshua A. Snively, Sr.
|
|
EVP, Research and Innovation
|
|
$392,600
|
|
$409,000
|
|
4.18%
|
Robert M. Schmitz
|
|
EVP and Chief Financial Officer
|
|
*
|
|
$330,000
|
|
*
|
H. Richard Walton
|
|
Chief Financial Officer Emeritus
|
|
$336,000
|
|
$350,000
|
|
4.17%
|
*
|
Mr. Schmitz was appointed Executive Vice President and Chief Financial Officer effective May 1, 2015 and is now considered a named executive officer.
|
Percent of Base Salary
|
|
John W. Chisholm
|
100%
|
Steven A. Reeves
|
75%
|
Joshua A. Snively, Sr.
|
60%
|
Robert M. Schmitz
|
70%
|
H. Richard Walton
|
70%
|
2015 Cash Bonus Performance Measure
|
||||
Adjusted EBITDA:
|
|
|
||
Minimum (50%)
|
|
Target (100%)
|
|
Maximum (200%)
|
$45.0 million
|
|
$55.0 million
|
|
$75.0 million
|
|
|
Minimum
|
|
Target
|
|
Maximum
|
|
Earned*
|
|
Discretionary
|
||||||||||
|
|
50%
|
|
100%
|
|
200%
|
|
0%
|
|
Award
|
||||||||||
John W. Chisholm
|
|
$
|
410,000
|
|
|
$
|
820,000
|
|
|
$
|
1,640,000
|
|
|
$
|
—
|
|
|
$
|
246,000
|
|
Steven A. Reeves
|
|
$
|
163,125
|
|
|
$
|
326,250
|
|
|
$
|
652,500
|
|
|
$
|
—
|
|
|
$
|
97,875
|
|
Joshua A. Snively, Sr.
|
|
$
|
122,700
|
|
|
$
|
245,400
|
|
|
$
|
490,800
|
|
|
$
|
—
|
|
|
$
|
73,620
|
|
Robert M. Schmitz
|
|
$
|
115,500
|
|
|
$
|
231,000
|
|
|
$
|
462,000
|
|
|
$
|
—
|
|
|
$
|
69,300
|
|
H. Richard Walton
|
|
$
|
122,500
|
|
|
$
|
245,000
|
|
|
$
|
490,000
|
|
|
$
|
—
|
|
|
$
|
73,500
|
|
*
|
As described above, a portion of earned value of bonuses took the form of restricted stock if elected by the executive. Such shares would vest upon certification by the Compensation Committee of the Board that performance requirements for vesting were met. The number of shares associated with this election were: Mr. Chisholm -
24,506
shares; Mr. Reeves -
9,750
shares; Mr. Snively -
7,334
shares; Mr. Schmitz -
5,439
shares; and Mr. Walton -
7,322
shares.
|
Percent of Base Salary
|
|
John W. Chisholm
|
375%
|
Steven A. Reeves
|
200%
|
Joshua A. Snively, Sr.
|
190%
|
Robert M. Schmitz
|
200%
|
H. Richard Walton
|
200%
|
|
Minimum
|
|
Target
|
|
Maximum
|
|
Actual
(2)
|
Performance Percentage
|
50%
|
|
100%
|
|
200%
|
|
100%
|
Number of peers outperformed
(1)
|
2
|
|
5
|
|
8
|
|
7
|
Amounts in Shares
|
|
|
|
|
|
|
|
John W. Chisholm
|
88,413
|
|
176,826
|
|
353,652
|
|
176,826
|
Steven A. Reeves
|
25,015
|
|
50,029
|
|
100,058
|
|
50,029
|
Joshua A. Snively, Sr.
|
22,344
|
|
44,687
|
|
89,374
|
|
44,687
|
Robert M. Schmitz
|
18,977
|
|
37,953
|
|
75,906
|
|
37,953
|
H. Richard Walton
|
20,127
|
|
40,254
|
|
80,508
|
|
40,254
|
(1)
|
The Performance Percentage earned between minimum and target and between target and maximum is determined on a linear basis. If the Company fails to outperform 2 peers, the bonus percentage is zero.
|
(2)
|
Although actual Total Shareholder Return exceeded the established target level, the Performance Percentage (and number of Earned Shares) was limited to a cap of 100% because the Company’s Total Shareholder Return was a loss of greater than 5%.
|
Chief Executive Base Salary
|
|
2015
|
|
2016
|
||||
John W. Chisholm *
|
|
$
|
820,000
|
|
|
$
|
820,000
|
|
*
|
Includes amounts paid to the Chisholm Companies under the Service Agreement and salary paid under the Letter Agreement with Mr. Chisholm.
|
Executive Officer Base Salary
|
|
2015
|
|
2016
|
||||
Steven A. Reeves
|
|
$
|
435,000
|
|
|
$
|
435,000
|
|
Joshua A. Snively, Sr.
|
|
$
|
409,000
|
|
|
$
|
425,400
|
|
Robert M. Schmitz
|
|
$
|
330,000
|
|
|
$
|
350,000
|
|
H. Richard Walton
|
|
$
|
350,000
|
|
|
$
|
330,000
|
|
Percent of Base Salary
|
||
John W. Chisholm
|
110
|
%
|
Steven A. Reeves
|
85
|
%
|
Joshua A. Snively, Sr.
|
75
|
%
|
Robert M. Schmitz
|
75
|
%
|
H. Richard Walton
|
75
|
%
|
Percent of Base Salary
|
||
John W. Chisholm
|
375
|
%
|
Steven A. Reeves
|
200
|
%
|
Joshua A. Snively, Sr.
|
190
|
%
|
Robert M. Schmitz
|
200
|
%
|
H. Richard Walton
|
200
|
%
|
Name and Principal Position
|
|
Year
|
|
Salary
|
|
Bonus
|
|
|
Stock
Awards
|
|
|
Option
Awards
|
|
|
All Other
Compensation
|
|
|
Total
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
John W. Chisholm – President, Chief
Executive Officer and Chairman of the Board |
|
2015
|
|
$
|
50,000
|
|
|
$
|
246,000
|
|
(1)
|
|
$
|
4,079,374
|
|
(2)
|
|
$
|
—
|
|
|
|
$
|
770,000
|
|
|
|
$
|
5,145,374
|
|
|
2014
|
|
$
|
50,000
|
|
|
$
|
1,234,450
|
|
|
|
$
|
3,663,147
|
|
(2)
|
|
$
|
—
|
|
|
|
$
|
722,500
|
|
|
|
$
|
5,670,097
|
|
|
|
2013
|
|
$
|
48,000
|
|
|
$
|
450,000
|
|
|
|
$
|
1,612,519
|
|
(4)
|
|
$
|
—
|
|
|
|
$
|
686,750
|
|
|
|
$
|
2,797,269
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Steven A. Reeves – Executive Vice
President, Operations |
|
2015
|
|
$
|
434,346
|
|
|
$
|
97,875
|
|
(1)
|
|
$
|
1,154,169
|
|
(2)
|
|
$
|
—
|
|
|
|
$
|
22,565
|
|
|
|
$
|
1,708,955
|
|
|
2014
|
|
$
|
414,500
|
|
|
$
|
454,530
|
|
|
|
$
|
1,374,186
|
|
(2)
|
|
$
|
—
|
|
|
|
$
|
21,924
|
|
|
|
$
|
2,265,140
|
|
|
|
2013
|
|
$
|
405,000
|
|
|
$
|
182,250
|
|
|
|
$
|
621,267
|
|
(4)
|
|
$
|
—
|
|
|
|
$
|
20,109
|
|
|
|
$
|
1,228,626
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Joshua A. Snively, Sr.– Executive Vice
President, Research and Innovation and President of Florida Chemical Company, Inc. |
|
2015
|
|
$
|
408,369
|
|
|
$
|
73,620
|
|
(1)
|
|
$
|
1,030,929
|
|
(2)
|
|
$
|
—
|
|
|
|
$
|
3,750
|
|
|
|
$
|
1,516,668
|
|
|
2014
|
|
$
|
388,535
|
|
|
$
|
549,546
|
|
|
|
$
|
1,786,141
|
|
(2)(3)
|
|
$
|
—
|
|
|
|
$
|
1,819
|
|
|
|
$
|
2,726,041
|
|
|
|
2013
|
|
$
|
232,308
|
|
|
$
|
—
|
|
|
|
$
|
—
|
|
|
|
$
|
—
|
|
|
|
$
|
1,819
|
|
|
|
$
|
234,127
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Robert M. Schmitz – Executive Vice
President and Chief Financial Officer |
|
2015
|
|
$
|
304,308
|
|
|
$
|
69,300
|
|
(1)
|
|
$
|
447,757
|
|
(2)
|
|
$
|
—
|
|
|
|
$
|
7,295
|
|
|
|
$
|
828,660
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
H. Richard Walton – Chief Financial
Officer Emeritus |
|
2015
|
|
$
|
349,462
|
|
|
$
|
73,500
|
|
(1)
|
|
$
|
928,659
|
|
(2)
|
|
$
|
—
|
|
|
|
$
|
12,000
|
|
|
|
$
|
1,363,621
|
|
|
2014
|
|
$
|
333,039
|
|
|
$
|
391,560
|
|
|
|
$
|
1,199,262
|
|
(2)
|
|
$
|
—
|
|
|
|
$
|
6,661
|
|
|
|
$
|
1,930,522
|
|
|
|
2013
|
|
$
|
252,161
|
|
|
$
|
146,250
|
|
|
|
$
|
568,735
|
|
(4)
|
|
$
|
—
|
|
|
|
$
|
4,000
|
|
|
|
$
|
971,146
|
|
(1)
|
Mr. Chisholm, Mr. Reeves, Mr. Snively, Mr. Schmitz, and Mr. Walton did not receive a bonus as part of the
2015
Annual Bonus Plan (MIP) as the Adjusted EBITDA targets were not met during
2015
. Mr. Chisholm, Mr. Reeves, Mr. Snively, Mr. Schmitz, and Mr. Walton received a discretionary bonus for
2015
of
$246,000
,
$97,875
,
$73,620
,
$69,300
, and
$73,500
, respectively.
|
(2)
|
Represents the aggregate grant date fair value of performance-based restricted stock unit awards made in
2015
and
2014
. These performance-based awards have market and service conditions and the aggregate grant date fair value was calculated using the Monte Carlo simulation model.
|
(3)
|
The amount also reflects the grant date fair value, calculated in accordance with ASC Topic 718, of 22,379 shares of restricted stock awards granted on February 5, 2014.
|
(4)
|
During
2013
, the performance-based restricted stock unit awards had performance and service conditions and the aggregate grant date fair value, at the target 100% level, was based on the fair market value of the Company’s Common Stock at the date of grant.
|
Name
|
|
Year
|
|
Company
Provided
Vehicle
(1)
|
|
Company
Provided
Housing
|
|
Company
Match
401 (k)
|
|
Services and
Consulting
Contracts
(2)
|
|
All Other
Compensation
|
||||||||||
John W. Chisholm
|
|
2015
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
770,000
|
|
|
$
|
770,000
|
|
|
|
2014
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
722,500
|
|
|
$
|
722,500
|
|
|
|
2013
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
686,750
|
|
|
$
|
686,750
|
|
Steven A. Reeves
|
|
2015
|
|
$
|
600
|
|
|
$
|
13,599
|
|
|
$
|
8,366
|
|
|
$
|
—
|
|
|
$
|
22,565
|
|
|
|
2014
|
|
$
|
600
|
|
|
$
|
13,034
|
|
|
$
|
8,290
|
|
|
$
|
—
|
|
|
$
|
21,924
|
|
|
|
2013
|
|
$
|
600
|
|
|
$
|
12,030
|
|
|
$
|
7,479
|
|
|
$
|
—
|
|
|
$
|
20,109
|
|
Joshua A. Snively, Sr.
|
|
2015
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
3,750
|
|
|
$
|
—
|
|
|
$
|
3,750
|
|
|
|
2014
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
1,819
|
|
|
$
|
—
|
|
|
$
|
1,819
|
|
|
|
2013
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
1,819
|
|
|
$
|
—
|
|
|
$
|
1,819
|
|
Robert M. Schmitz
|
|
2015
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
7,295
|
|
|
$
|
—
|
|
|
$
|
7,295
|
|
H. Richard Walton
|
|
2015
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
12,000
|
|
|
$
|
—
|
|
|
$
|
12,000
|
|
|
|
2014
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
6,661
|
|
|
$
|
—
|
|
|
$
|
6,661
|
|
|
|
2013
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
4,000
|
|
|
$
|
—
|
|
|
$
|
4,000
|
|
(1)
|
The expenses for all Company provided vehicles were determined through averaging the FMV, odometer reading, and estimated percentage personal use.
|
(2)
|
Amounts received by Mr. Chisholm are related to his Service Agreement with the Company.
|
Name
|
|
Grant
Date
|
|
Estimated Future Payouts
Under Non-Equity Incentive
Plan Awards
|
|
Estimated Future Payouts
Under Equity Incentive
Plan Awards
|
|
All Other Stock Awards: Number of Shares of Stock or Units
|
All Other Option Awards: Number of Securities Underlying Options
|
Exercise or Base Price of Option Awards
|
|
Grant Date Fair Value for Stock and Option Awards
|
|
||||||||||||||||||||||
|
Threshold
|
Target
(1)
|
Maximum
|
|
Threshold
(Shares) |
Target
(Shares)
|
Maximum
(Shares)
|
|
|
||||||||||||||||||||||||||
John W. Chisholm
|
|
3/2/2015
|
|
$
|
410,000
|
|
$
|
820,000
|
|
$
|
1,640,000
|
|
|
—
|
|
—
|
|
—
|
|
|
—
|
|
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
|
|
1/9/2015
|
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
|
|
88,413
|
|
176,826
|
|
353,652
|
|
|
—
|
|
|
—
|
|
|
$
|
—
|
|
|
$
|
4,079,374
|
|
(2
|
)
|
Steven A. Reeves
|
|
3/2/2015
|
|
$
|
163,125
|
|
$
|
326,250
|
|
$
|
652,500
|
|
|
—
|
|
—
|
|
—
|
|
|
—
|
|
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
|
|
1/9/2015
|
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
|
|
25,015
|
|
50,029
|
|
100,058
|
|
|
—
|
|
|
—
|
|
|
$
|
—
|
|
|
$
|
1,154,169
|
|
(2
|
)
|
Joshua A. Snively, Sr.
|
|
3/2/2015
|
|
$
|
122,700
|
|
$
|
245,400
|
|
$
|
490,800
|
|
|
—
|
|
—
|
|
—
|
|
|
—
|
|
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
|
|
1/9/2015
|
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
|
|
22,344
|
|
44,687
|
|
89,374
|
|
|
—
|
|
|
—
|
|
|
$
|
—
|
|
|
$
|
1,030,929
|
|
(2
|
)
|
Robert M. Schmitz
|
|
3/2/2015
|
|
$
|
115,500
|
|
$
|
231,000
|
|
$
|
462,000
|
|
|
—
|
|
—
|
|
—
|
|
|
—
|
|
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
|
|
1/9/2015
|
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
|
|
7,476
|
|
14,952
|
|
29,904
|
|
|
—
|
|
|
—
|
|
|
$
|
—
|
|
|
$
|
344,943
|
|
(2
|
)
|
|
|
5/29/2015
|
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
|
|
11,501
|
|
23,001
|
|
46,002
|
|
|
—
|
|
|
—
|
|
|
$
|
—
|
|
|
$
|
102,814
|
|
(3
|
)
|
H. Richard Walton
|
|
3/2/2015
|
|
$
|
122,500
|
|
$
|
245,000
|
|
$
|
490,000
|
|
|
—
|
|
—
|
|
—
|
|
|
—
|
|
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
|
|
1/9/2015
|
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
|
|
20,127
|
|
40,254
|
|
80,508
|
|
|
—
|
|
|
—
|
|
|
$
|
—
|
|
|
$
|
928,659
|
|
(2
|
)
|
(1)
|
At the date of grant, Mr. Chisholm, Mr. Reeves, Mr. Snively, Mr. Schmitz, and Mr. Walton elected to received one-half of the target value of their 2015 Annual Bonus Plan (MIP) opportunity in the form of restricted shares. The value assigned to determine the shares, and the number of shares, based on the closing stock price on
March 2, 2015
, were as follows: Mr. Chisholm -
$410,000
,
24,506
shares; Mr. Reeves -
$163,125
,
9,750
shares; Mr. Snively -
$122,700
,
7,334
shares; Mr. Schmitz -
$91,000
,
5,439
shares; and Mr. Walton -
$122,500
,
7,322
shares.
|
(2)
|
Grant date fair value is determined in accordance with ASC Topic 718 and, for the performance-based restricted share units which have a market condition, is the value at grant date based on the probable outcome of the performance condition and is consistent with the estimate of aggregate compensation cost to be recognized over the service period.
|
(3)
|
Mr. Schmitz was appointed to Executive Vice President and Chief Financial Officer effective May 1, 2015. His equity incentive plan award was adjusted for his new role with the Company. Grant date fair value is determined in accordance with ASC Topic 718 and, for the performance-based restricted share units which have a market condition, is the value at grant date based on the probable outcome of the performance condition and is consistent with the estimate of aggregate compensation cost to be recognized over the service period.
|
Option Awards
|
|||||||||||||||||
Name
|
|
Year of
Grant
|
|
Number of
Securities
Underlying
Unexercised
Options
Exercisable
|
|
Number of
Securities
Underlying
Unexercised
Options
Unexercisable
|
|
Equity Incentive Plan Awards: Number of Securities Underlying Unexercised Unearned Options
|
|
Option
Exercise
Price
|
|
Option
Expiration
Date
|
|||||
John W. Chisholm
|
|
2011
|
|
400,000
|
|
|
—
|
|
|
—
|
|
|
$
|
9.19
|
|
|
4/8/2017
|
Steven A. Reeves
|
|
2011
|
|
200,000
|
|
|
—
|
|
|
—
|
|
|
$
|
9.19
|
|
|
4/8/2017
|
Restricted Stock Awards
|
||||||||||||||||||||
Name
|
|
Year of Grant
|
|
Number of
Shares or Units of Stock
That Have Not
Vested
|
|
|
|
Market Value of Shares or Units of Stock
That Have Not Vested
(1)
|
|
Equity Incentive Plan
Awards: Number of
Unearned Shares, Units
or Other Rights That
Have Not Vested
|
|
|
|
Equity Incentive Plan
Awards: Market or
Payout Value of
Unearned Shares, Units
or Other Rights That
Have Not Vested
(1)
|
||||||
John W. Chisholm
|
|
2013
|
|
24,656
|
|
|
(2)
|
|
$
|
282,065
|
|
|
—
|
|
|
|
|
$
|
—
|
|
|
|
2014
|
|
74,258
|
|
|
(5)
|
|
$
|
849,512
|
|
|
—
|
|
|
|
|
$
|
—
|
|
|
|
2015
|
|
—
|
|
|
|
|
$
|
—
|
|
|
24,506
|
|
|
(7)
|
|
$
|
280,349
|
|
|
|
2015
|
|
—
|
|
|
|
|
$
|
—
|
|
|
176,826
|
|
|
(8)
|
|
$
|
2,022,889
|
|
Steven A. Reeves
|
|
2013
|
|
9,499
|
|
|
(2)
|
|
$
|
108,669
|
|
|
—
|
|
|
|
|
$
|
—
|
|
|
|
2014
|
|
27,857
|
|
|
(5)
|
|
$
|
318,684
|
|
|
—
|
|
|
|
|
$
|
—
|
|
|
|
2015
|
|
—
|
|
|
|
|
$
|
—
|
|
|
9,750
|
|
|
(7)
|
|
$
|
111,540
|
|
|
|
2015
|
|
—
|
|
|
|
|
$
|
—
|
|
|
50,029
|
|
|
(8)
|
|
$
|
572,332
|
|
Joshua A. Snively, Sr.
|
|
2014
|
|
7,459
|
|
|
(4)
|
|
$
|
85,331
|
|
|
—
|
|
|
|
|
$
|
—
|
|
|
|
2014
|
|
26,164
|
|
|
(5)
|
|
$
|
299,316
|
|
|
—
|
|
|
|
|
$
|
—
|
|
|
|
2015
|
|
—
|
|
|
|
|
$
|
—
|
|
|
7,334
|
|
|
(7)
|
|
$
|
83,901
|
|
|
|
2015
|
|
—
|
|
|
|
|
$
|
—
|
|
|
44,687
|
|
|
(8)
|
|
$
|
511,219
|
|
Robert M. Schmitz
|
|
2013
|
|
5,000
|
|
|
(3)
|
|
$
|
57,200
|
|
|
—
|
|
|
|
|
$
|
—
|
|
|
|
2014
|
|
6,666
|
|
|
(6)
|
|
$
|
76,259
|
|
|
—
|
|
|
|
|
$
|
—
|
|
|
|
2014
|
|
5,655
|
|
|
(5)
|
|
$
|
64,693
|
|
|
—
|
|
|
|
|
$
|
—
|
|
|
|
2015
|
|
—
|
|
|
|
|
$
|
—
|
|
|
5,439
|
|
|
(7)
|
|
$
|
62,222
|
|
|
|
2015
|
|
—
|
|
|
|
|
$
|
—
|
|
|
37,953
|
|
|
(8)
|
|
$
|
434,182
|
|
H. Richard Walton
|
|
2013
|
|
8,696
|
|
|
(2)
|
|
$
|
99,482
|
|
|
—
|
|
|
|
|
$
|
—
|
|
|
|
2014
|
|
24,311
|
|
|
(5)
|
|
$
|
278,118
|
|
|
—
|
|
|
|
|
$
|
—
|
|
|
|
2015
|
|
—
|
|
|
|
|
$
|
—
|
|
|
7,322
|
|
|
(7)
|
|
$
|
83,764
|
|
|
|
2015
|
|
—
|
|
|
|
|
$
|
—
|
|
|
40,254
|
|
|
(8)
|
|
$
|
460,506
|
|
(1)
|
The dollar value of the unvested shares of restricted stock reported are valued at the closing price of Flotek’s Common Stock on
December 31, 2015
(
$11.44
per share).
|
(2)
|
The total number of unvested shares represents the unvested portion of performance shares earned during 2013. These shares vest on February 5, 2016.
|
(3)
|
The total number of unvested shares of restricted stock granted on June 17, 2013. These shares vest on June 17, 2016.
|
(4)
|
The total number of unvested shares of restricted stock granted on February 5, 2014. These shares vest on February 5, 2016.
|
(5)
|
The total number of unvested shares represents the unvested portion of performance shares earned during 2014. These shares vest on December 31, 2016.
|
(6)
|
The total number of unvested shares of restricted stock granted on May 16, 2014. These shares vest as follows: 50% on February 11, 2016 and 50% on February 11, 2017.
|
(7)
|
The total number of unvested shares elected by the named executive as part of the 2015 Management Incentive Plan. These shares are forfeitable to the extent that performance targets are not met for 2015. The shares will be adjusted during 2016 for actual performance during 2015.
|
(8)
|
The total number of unearned performance shares available for 2015, at the target 100% level. The shares will be adjusted during 2016 for actual performance during 2015.
|
|
|
Option Awards
|
|
Restricted Stock Awards
|
||||||||||
Name
|
|
Number of
Shares Acquired
on Exercise
|
|
Value Realized
on Exercise
|
|
Number of
Shares Acquired
on Vesting
|
|
Value Realized
on Vesting
|
||||||
John W. Chisholm
|
|
746,668
|
|
|
$
|
8,188,087
|
|
|
125,815
|
|
|
$
|
1,710,483
|
|
Steve A. Reeves
|
|
—
|
|
|
$
|
—
|
|
|
47,275
|
|
|
$
|
643,032
|
|
Joshua A. Snively, Sr.
|
|
—
|
|
|
$
|
—
|
|
|
38,109
|
|
|
$
|
502,497
|
|
Robert M. Schmitz
|
|
—
|
|
|
$
|
—
|
|
|
16,345
|
|
|
$
|
218,372
|
|
H. Richard Walton
|
|
—
|
|
|
$
|
—
|
|
|
61,846
|
|
|
$
|
862,571
|
|
Name and Participant Position
|
|
Termination
Event
|
|
Severance
|
|
Pro-Rata Bonus
|
|
Health Benefits
|
|
Acceleration
of Unvested
Equity
|
|
Total
|
||||||||||
John W. Chisholm (1)
|
|
Change In Control
|
|
$
|
3,280,000
|
|
|
$
|
410,000
|
|
|
$
|
—
|
|
|
$
|
3,434,814
|
|
|
$
|
7,124,814
|
|
President, Chief Executive Officer and
|
|
Good Reason
|
|
$
|
3,280,000
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
3,280,000
|
|
Chairman of the Board
|
|
Without Cause
|
|
$
|
3,280,000
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
3,280,000
|
|
|
|
Death or Disability
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
3,434,814
|
|
|
$
|
3,434,814
|
|
Steve A. Reeves (2)
|
|
Change In Control
|
|
$
|
507,500
|
|
|
$
|
163,125
|
|
|
$
|
30,528
|
|
|
$
|
1,111,224
|
|
|
$
|
1,812,377
|
|
Executive Vice President, Operations
|
|
Good Reason
|
|
$
|
507,500
|
|
|
$
|
—
|
|
|
$
|
30,528
|
|
|
$
|
—
|
|
|
$
|
538,028
|
|
|
|
Without Cause
|
|
$
|
507,500
|
|
|
$
|
—
|
|
|
$
|
30,528
|
|
|
$
|
—
|
|
|
$
|
538,028
|
|
|
|
Death or Disability
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
1,111,224
|
|
|
$
|
1,111,224
|
|
Joshua A. Snively, Sr. (3)
|
|
Change In Control
|
|
$
|
490,800
|
|
|
$
|
122,700
|
|
|
$
|
—
|
|
|
$
|
979,767
|
|
|
$
|
1,593,267
|
|
Executive Vice President, Research &
|
|
Good Reason
|
|
$
|
490,800
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
490,800
|
|
Innovation, President of Florida
|
|
Without Cause
|
|
$
|
490,800
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
490,800
|
|
Chemical Company, Inc.
|
|
Death or Disability
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
979,767
|
|
|
$
|
979,767
|
|
Robert M. Schmitz (4)
|
|
Change In Control
|
|
$
|
420,750
|
|
|
$
|
140,000
|
|
|
$
|
—
|
|
|
$
|
694,557
|
|
|
$
|
1,255,307
|
|
Executive Vice President and
|
|
Good Reason
|
|
$
|
420,750
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
420,750
|
|
Chief Financial Officer
|
|
Without Cause
|
|
$
|
420,750
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
420,750
|
|
|
|
Death or Disability
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
694,557
|
|
|
$
|
694,557
|
|
H. Richard Walton (5)
|
|
Change In Control
|
|
$
|
446,250
|
|
|
$
|
122,500
|
|
|
$
|
—
|
|
|
$
|
921,870
|
|
|
$
|
1,490,620
|
|
Chief Financial Officer Emeritus
|
|
Good Reason
|
|
$
|
446,250
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
446,250
|
|
|
|
Without Cause
|
|
$
|
446,250
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
446,250
|
|
|
|
Death or Disability
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
921,870
|
|
|
$
|
921,870
|
|
(i)
|
Any person (subject to certain exceptions) becomes the beneficial owner, directly or indirectly, of securities of the Company representing fifty percent (50%) or more of the combined voting power of the Company’s then outstanding securities;
|
(ii)
|
During any period of one (1) year, individuals who at the beginning of such period constitute the Board (and any new Director whose election by the Corporation’s stockholders was approved by a vote of at least two-thirds (2/3) of the Directors then still in office who either were Directors at the beginning of the period or whose election or nomination for election was so approved) cease for any reason to constitute a majority thereof; or
|
(iii)
|
(A) The sale or disposition of all or substantially all the Company’s assets, or (B) a merger, consolidation, or reorganization of the Company with or involving any other entity, other than a merger, consolidation, or reorganization that would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) at least fifty percent (50%) of the combined voting power of the securities of the Company (or such surviving entity) outstanding immediately after such merger, consolidation, or reorganization.
|
(i)
|
A material reduction of the employee’s salary and employee benefits to which the employee was entitled immediately prior to such reduction;
|
(ii)
|
A material reduction in the duties, authority or responsibilities relative to the employee’s duties, authority or responsibilities as in effect immediately prior to such reduction; or
|
(iii)
|
The relocation of the employee to a facility or a location more than fifty (50) miles from the employee’s then present location;
|
(i)
|
An employee willfully fails to substantially perform the employee’s duties (other than any such failure resulting from the employee’s total and permanent disability) after a written demand for substantial performance has been delivered by the Company to the employee that specifically identifies the manner in which the Company believes that the employee has not substantially performed the employee’s duties, and the employee fails to remedy such failure within ten (10) calendar days after receiving such notice;
|
(ii)
|
An employee is convicted (by trial, plea of guilty, or plea of nolo contendere) for committing an act of fraud, embezzlement, theft, or other act constituting a felony;
|
(iii)
|
An employee willfully engages in gross misconduct or willfully violates a Company or a subsidiary policy which is materially and demonstrably injurious to the Company and/or a subsidiary after a written demand to cease such misconduct or violation has been delivered by the Company to the employee that specifically identifies the manner in which the Company believes that the employee has violated this Paragraph (iii), and the employee fails to cease such misconduct or violation and remedy any injury suffered by the Company or the subsidiary as a result thereof within thirty (30) calendar days after receiving such notice. However, no act or failure to act, on the employee’s part shall be considered “willful” unless done, or omitted to be done, by the employee not in good faith and without reasonable belief that the employee’s action or omission was in the best interest of the Company or the subsidiary; or
|
(iv)
|
An employee commits a material breach of any noncompetition, confidentiality or similar agreement with the Company or a subsidiary, as determined under such agreement.
|
(1)
|
Upon termination of employment between Flotek and the Chisholm Companies pursuant to the Service Agreement and the employment of Mr. Chisholm pursuant to his Letter Agreement (a) for Good Reason or without Cause pursuant to a Change in Control, the Chisholm Companies would be entitled to receive (i) severance compensation equal to two hundred percent of base compensation and target bonus in effect for the year in which termination occurs and (ii) accelerated vesting of all unvested RSAs. If employment of the Chisholm Companies is terminated for (b) Good Reason or (c) without Cause, the Chisholm Companies shall be entitled to receive (i) severance compensation equal to two hundred percent of base compensation and target bonus in effect for the year in which the termination occurs and (ii) accelerated vesting of certain RSAs provided in the individual grant agreements. If employment of the Chisholm Companies were to be terminated by (d) death or disability, the Chisholm Companies would be entitled to receive (i) base compensation earned and payable through the date of termination and (ii) the accelerated vesting of all RSAs.
|
(2)
|
Upon termination of employment between Flotek and Mr. Reeves (a) for Good Reason or without Cause pursuant to a Change in Control, Mr. Reeves would be entitled to receive (i) severance compensation equal to two-thirds of his base salary and target bonus in effect for the year in which termination occurs, (ii) continued health care for two years and (iii) accelerated vesting of all unvested RSAs. If employment of Mr. Reeves is terminated for (b) Good Reason or (c) without Cause prior to the Expiration Date, he is entitled to receive (i) severance compensation equal to two-thirds of his base salary and target bonus in effect for the year in which the termination occurs (ii) continued health care for two years and (iii) accelerated vesting of certain RSAs provided in the individual grant agreements. If the employment of Mr. Reeves were to be terminated by (d) death or disability, Mr. Reeves would be entitled to receive (i) base salary earned and payable through the date of termination and (ii) the accelerated vesting of all RSAs.
|
(3)
|
Upon termination of employment between Flotek and Mr. Snively (a) for Good Reason or without Cause pursuant to a Change in Control, Mr. Snively would be entitled to receive (i) severance compensation equal to 75% of his base salary and target bonus in effect for the year in which termination occurs and (ii) accelerated vesting of all unvested RSAs. If employment of Mr. Snively is terminated for (b) Good Reason or (c) without Cause prior to the Expiration Date, he is entitled to receive (i) severance compensation equal to 75% of his base salary and target bonus in effect for the year in which the termination occurs and (ii) accelerated vesting of certain RSAs provided in the individual grant agreements. If the employment of Mr. Snively were to be terminated by (d) death or disability, Mr. Snively would be entitled to receive (i) base salary earned and payable through the date of termination and (ii) the accelerated vesting of all RSAs.
|
(4)
|
Upon termination of employment between Flotek and Mr. Schmitz (a) for Good Reason or without Cause pursuant to a Change in Control, Mr. Schmitz would be entitled to receive (i) severance compensation equal to 75% of his base salary and target bonus in effect for the year in which termination occurs and (ii) accelerated vesting of all unvested RSAs. If employment of Mr. Schmitz is terminated for (b) Good Reason or (c) without Cause prior to the the Expiration date, he is entitled to receive (i) severance compensation equal to 75% of his base salary and target bonus in effect for the year in which the termination occurs and (ii) accelerated vesting of certain RSAs provided in the individual grant agreements. If the employment of Mr. Schmitz were to be terminated by (d) death or disability, Mr. Schmitz would be entitled to receive (i) base salary earned and payable through the date of termination and (ii) the accelerated vesting of all RSAs.
|
(5)
|
Upon termination of employment between Flotek and Mr. Walton (a) for Good Reason or without Cause pursuant to a Change in Control, Mr. Walton would be entitled to receive (i) severance compensation equal to 75% of his base salary and target bonus in effect for the year in which termination occurs and (ii) accelerated vesting of all unvested RSAs. If employment of Mr. Walton is terminated for (b) Good Reason or (c) without Cause prior to the Expiration Date, he is entitled to receive (i) severance compensation equal to 75% of his base salary and target bonus in effect for the year in which the termination occurs and (ii) accelerated vesting of certain RSAs provided in the individual grant agreements. If the employment of Mr. Walton were to be terminated by (d) death or disability, Mr. Walton would be entitled to receive (i) base salary earned and payable through the date of termination and (ii) the accelerated vesting of all RSAs.
|
Director
|
Audit
|
Corporate
Governance
and
Nominating
|
Compensation
|
Kenneth T. Hern
|
X
|
C
|
X
|
John S. Reiland
|
C
|
X
|
X
|
L.V. “Bud” McGuire
|
|
X
|
X
|
L. Melvin Cooper
|
X
|
X
|
X
|
Carla S. Hardy
|
|
X
|
C
|
Ted D. Brown
|
|
X
|
X
|
•
|
Appoint, determine funding for, oversee, and replace (subject to stockholder ratification, if applicable) a firm of independent auditors to audit our financial statements;
|
•
|
Pre-approve all audit and non-audit services provided by our independent auditors;
|
•
|
Evaluate the qualifications, performance and independence of our independent auditors, and ensure the rotation of the lead (or concurring) audit partner;
|
•
|
Obtain and review a report of our independent auditors, at least annually, regarding compliance with their internal quality-control procedures;
|
•
|
Discuss with our independent auditors the overall scope and plans for their respective audits;
|
•
|
Discuss with management and our independent auditors the adequacy and effectiveness of the Company’s accounting and financial controls;
|
•
|
Meet with our independent auditors to discuss the conduct and findings of their respective audits;
|
•
|
Meet and review with management and our independent auditors the Company’s financial statements and the associated disclosures to be included in quarterly and annual reports to be filed with the SEC;
|
•
|
Discuss with management and our independent auditors significant financial reporting issues and judgments made in connection with the preparation of the Company’s financial statements;
|
•
|
Discuss periodically with management the Company’s plan with regards to issuing earnings press releases and
|
•
|
Review any disclosures by the Company’s officers and other employees regarding significant deficiencies in the design and operation of the Company’s internal controls; and
|
•
|
Establish procedures for receiving and responding to concerns regarding accounting, internal accounting controls, and auditing matters.
|
•
|
Review, at least annually, the structure of the Board to assure that the proper skills and experience are represented on the Board;
|
•
|
Recommend to the full Board candidates to fill vacancies on the Board as they occur;
|
•
|
Recommend, prior to each annual stockholder meeting, a slate of nominees for election or reelection as directors by the stockholders at the annual meeting;
|
•
|
Identify individuals qualified to serve as potential Board members, consistent with criteria approved by the Board;
|
•
|
Select, evaluate, retain, and where appropriate, terminate any search firm to be used to identify qualified director candidates;
|
•
|
Evaluate current directors for re-nomination to the Board or re-appointment to any Board committees, and assess the performance of such directors;
|
•
|
Periodically review the composition of the Board and its committees in light of the current challenges and needs of the Board, the Company and each committee of the Board, and determine whether it may be appropriate to add or remove individuals;
|
•
|
Consider rotation of the Chairman and members of the committees of the Board;
|
•
|
Consider candidates to serve as Board members that are submitted by stockholders of the Company;
|
•
|
Periodically make recommendations to the Board with respect to the size of the Board;
|
•
|
Review criteria and policies relating to director independence, service, and tenure;
|
•
|
Recommend to the Board the membership of the Audit and Compensation Committees, including their Chairpersons;
|
•
|
Make recommendations to the Board regarding corporate governance matters and practices, including formulating and periodically reviewing Corporate Governance Guidelines to be adopted by the Board;
|
•
|
Develop and recommend to the Board the Company’s Corporate Governance Guidelines and, at least annually, review and reassess the adequacy of such Corporate Governance Guidelines and recommend any proposed changes to the Board;
|
•
|
Be responsible for any tasks assigned to the Corporate Governance and Nominating Committee in the Company’s Corporate Governance Guidelines;
|
•
|
Oversee compliance with the Company’s Corporate Governance Guidelines and Code of Business Conduct and Ethics and report on such compliance to the Board;
|
•
|
Review and consider any requests for waivers of the Company’s Corporate Governance Guidelines or Code of Business Conduct and Ethics for the Company’s directors, executive officers, and other senior financial officers and make a recommendation to the Board with respect to such request for a waiver;
|
•
|
Review potential conflicts of interest involving directors and determine whether such director or directors may vote on any issue as to which there may be a conflict;
|
•
|
Review all related party transactions and determine whether such transactions are appropriate for the Company to undertake and, if so, approve such transactions;
|
•
|
Review periodically with the Company’s counsel, in light of changing conditions, new legislation and other developments, the Company’s Code of Business Conduct and Ethics and make recommendations to the Board for such changes as the Corporate Governance and Nominating Committee shall deem appropriate; and
|
•
|
Review executive development and executive succession plans, including succession planning strategies for the Company’s senior management positions.
|
•
|
Adopt compensation policies and programs that are consistent with corporate strategy and meet all legal requirements regarding reporting and administration of compensation matters;
|
•
|
Establish, in conjunction with executive management, the overall compensation strategy of the Company and review such strategy, at least annually, for alignment with the Company’s business strategy and with similar programs offered by the Company’s competitors;
|
•
|
Oversee the compensation and benefits programs applicable to all employees of the Company;
|
•
|
Adopt, amend, or terminate corporate incentive programs (including short-term and long-term incentive and other similar programs), including establishment of performance standards, and determine the funding of such programs relative to previously established performance standards;
|
•
|
Review the Company’s employee benefit plans, including retirement and savings plans, and either recommend plan changes to the Board or amend such plans as appropriate;
|
•
|
Recommend to the Board the adoption of any new Company employee benefit plan or the termination of any existing employee benefit plan, as appropriate;
|
•
|
Review, at least annually, the Company’s investment strategies around and performance of the Company’s 401(k) plans;
|
•
|
Review and approve, at least annually, corporate goals and objectives relevant to compensation of the Company’s executive officers and employees who report directly to the Company’s Chief Executive Officer (collectively, the “CEO Direct Reports”) and evaluate each executive officer’s and CEO Direct Report’s performance in light of such goals and objectives;
|
•
|
Either as a Compensation Committee or in conjunction with the other independent directors (as directed by the
|
•
|
Regarding individual executive officer’s and CEO Direct Report’s compensation, consider a number of factors that include, but are not limited to, the Company’s financial and operational performance, relative shareholder return, the value of similar incentive awards to executives at comparable companies, awards given in past years, and the results of the most recent shareholder advisory vote on executive compensation;
|
•
|
Annually review and approve the annual base salaries and annual short-term and long-term incentive opportunities of the executive officers and CEO Direct Reports;
|
•
|
Periodically review and approve the following, as they affect executive officers and CEO Direct Reports: elements of compensation other than salaries and annual incentives; employment and severance agreements; change-in-control agreements and change-in-control provisions affecting any element of compensation or benefits; and any special or supplemental compensation and benefits for the executive officers, CEO Direct Reports, and individuals who formerly served as executive officers and CEO Direct Reports;
|
•
|
Award equity-based awards to executive officers, CEO Direct Reports, and to other employees of the Company pursuant to any plans approved by the Board which by its terms provide for administration by the Compensation Committee;
|
•
|
Make recommendations to the Board with respect to the compensation of Board members;
|
•
|
Assure that all compensation policies and programs comply with applicable laws and regulations;
|
•
|
Review and approve annual performance goals for performance-based compensation, including but not limited to performance goals for performance-based compensation that is intended to be tax deductible under Section 162(m) of the Internal Revenue Code, determine whether the performance goals and objectives are attained, and certify the level of attainment as applicable;
|
•
|
Review and approve annually the peer group used to assess the competitiveness of the Company
’s compensation programs, including executive compensation;
|
•
|
Review the Company’s compensation policies and practices to determine whether they encourage excessive risk-taking, discuss annually the relationship between risk management policies and practices and compensation, and evaluate compensation policies and practices that could mitigate any such risk;
|
•
|
Consider the factors affecting independence set forth in Section 303A.05(c)(iv) of the NYSE Listed Company Manual when selecting or soliciting advice from any external legal counsel, compensation consultants, or
|
•
|
Review and approve the frequency that should be recommended to the Company’s shareholders with respect to how often the Company shall hold a shareholder advisory vote on executive compensation (“Say on Pay Vote”); review and approve the frequency with which the Company should submit to the shareholders a Say on Pay Vote, taking into consideration any prior Say on Pay Vote on the frequency with which the Company shall hold a Say on Pay Vote; and review the results of the most recent Say on Pay Vote when considering whether to make any adjustments to the Company’s executive compensation policies and practices;
|
•
|
Review and discuss the Company’s Compensation Discussion and Analysis (“CD&A”) and the related executive compensation information and recommend that the CD&A and related executive compensation information be included in the Company’s proxy statement and annual report on Form 10-K as required by the rules and regulations of the Securities and Exchange Commission;
|
•
|
Approve the Compensation Committee report on executive officer compensation included in the Company’s proxy statement or annual report on Form 10-K as required by the rules and regulations of the Securities and Exchange Commission;
|
•
|
Receive reports on compensation and benefits applicable to all employees; and
|
•
|
Oversee the Company’s compliance with, and take any other actions as may be required from time to time by, applicable law, the rules of the NYSE, the rules and regulations of the Securities and Exchange Commission, the Bylaws or the Board, including any requirement that shareholders approve equity compensation plans.
|
Name
|
|
Board
Retainer (1) |
|
Committee
Chair Retainer (1) |
|
Meeting
Fees (1) |
|
Restricted
Stock Awards (2)(3) |
|
Option Awards
(4)
|
|
Total
|
||||||||||||
Kenneth T. Hern
|
|
$
|
64,000
|
|
|
$
|
12,000
|
|
|
$
|
44,000
|
|
|
$
|
120,002
|
|
|
$
|
—
|
|
|
$
|
240,002
|
|
John S. Reiland
|
|
40,000
|
|
|
24,000
|
|
|
44,000
|
|
|
120,002
|
|
|
—
|
|
|
228,002
|
|
||||||
L.V. “Bud” McGuire
|
|
40,000
|
|
|
—
|
|
|
31,000
|
|
|
120,002
|
|
|
—
|
|
|
191,002
|
|
||||||
L. Melvin Cooper
|
|
40,000
|
|
|
—
|
|
|
44,000
|
|
|
120,002
|
|
|
—
|
|
|
204,002
|
|
||||||
Carla S. Hardy
|
|
40,000
|
|
|
12,000
|
|
|
39,000
|
|
|
120,002
|
|
|
—
|
|
|
211,002
|
|
||||||
Ted D. Brown
|
|
40,000
|
|
|
—
|
|
|
39,000
|
|
|
120,002
|
|
|
—
|
|
|
199,002
|
|
Plan category
|
|
Number of Securities to be Issued Upon Exercise of Outstanding Options, Warrants and Rights
(2)
|
|
Weighted-Average Exercise Price of Outstanding Options, Warrants and Rights
(3)
|
|
Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans (Excluding Securities Reflected in Column (a))
|
||||
|
|
(a)
|
|
(b)
|
|
(c)
|
||||
Equity compensation plans approved by security holders
(1)
|
|
2,062,665
|
|
|
$
|
7.80
|
|
|
1,090,837
|
|
Equity compensation plans not approved by security holders
|
|
—
|
|
|
$
|
—
|
|
|
—
|
|
Total
|
|
2,062,665
|
|
|
$
|
7.80
|
|
|
1,090,837
|
|
(1)
|
Does not include the additional
2,500,000
shares that will become available for issuance under the Amended and Restated 2014 Long-Term Incentive Plan upon stockholder approval of Proposal 2.
|
(2)
|
Includes shares for outstanding stock options (777,400 shares), restricted stock awards (899,216 shares), and restricted stock unit share equivalents (386,049 shares).
|
(3)
|
The weighted-average exercise price is for outstanding stock options only and does not include outstanding restricted stock awards or restricted stock unit share equivalents that have no exercise price.
|
|
|
2015
|
|
2014
|
||||||||
Participant
|
|
Shares
|
|
%
|
|
Shares
|
|
%
|
||||
Named Executive Officers
|
|
753,849
|
|
(1)
|
64.0
|
%
|
|
354,023
|
|
(3)
|
48.6
|
%
|
Other Officers
|
|
82,409
|
|
(2)
|
7.0
|
%
|
|
64,112
|
|
(4)
|
8.8
|
%
|
Non-employee Directors
|
|
51,210
|
|
|
4.3
|
%
|
|
26,280
|
|
|
3.6
|
%
|
Employees
|
|
291,280
|
|
|
24.7
|
%
|
|
284,486
|
|
|
39.0
|
%
|
Total
|
|
1,178,748
|
|
|
100.0
|
%
|
|
728,901
|
|
|
100.0
|
%
|
(1)
|
Includes
349,749
shares to increase the long-term incentive award from target to maximum shares.
|
(2)
|
Includes
36,300
shares to increase the long-term incentive award from target to maximum shares.
|
(3)
|
Includes
152,590
shares to increase the long-term incentive award from target to maximum shares.
|
(4)
|
Includes
23,537
shares to increase the long-term incentive award from target to maximum shares.
|
Participant
|
|
Number of Restricted Stock Units
|
|
John W. Chisholm
|
|
341,667
|
|
Steven A. Reeves
|
|
96,667
|
|
Joshua A. Snively, Sr.
|
|
89,807
|
|
Robert M. Schmitz
|
|
77,778
|
|
H. Richard Walton
|
|
73,334
|
|
Other Officers
|
|
70,140
|
|
Non-employee Directors
|
|
—
|
|
Employees
|
|
—
|
|
Total restricted stock units
|
|
749,393
|
|
|
2015
|
|
2014
|
||||
Audit fees
|
$
|
589,000
|
|
|
$
|
691,247
|
|
Audit related fees
|
35,000
|
|
|
35,000
|
|
||
Tax fees
|
—
|
|
|
—
|
|
||
All other fees
|
—
|
|
|
—
|
|
||
Total
|
$
|
624,000
|
|
|
$
|
726,247
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
ARTICLE I. INTRODUCTION
|
|
1.1
|
Purpose
|
A-1
|
1.2
|
Definitions
|
A-1
|
1.3
|
Shares Subject to the Plan
|
A-5
|
1.4
|
Prohibition of Repricing Without Stockholder Approval
|
A-6
|
1.5
|
Administration of the Plan
|
A-6
|
1.6
|
Granting of Awards to Participants
|
A-7
|
1.7
|
Term of Plan
|
A-7
|
1.8
|
Amendment and Discontinuance of the Plan
|
A-8
|
|
ARTICLE II. NON-QUALIFIED OPTIONS
|
|
2.1
|
Eligibility
|
A-8
|
2.2
|
Exercise Price
|
A-8
|
2.3
|
Award Agreement
|
A-8
|
2.4
|
Terms and Conditions of Non-Qualified Options
|
A-8
|
2.5
|
Exercisability and Vesting
|
A-8
|
2.6
|
Option Repricing Prohibited
|
A-9
|
|
ARTICLE III. INCENTIVE STOCK OPTIONS
|
|
3.1
|
Eligibility
|
A-9
|
3.2
|
Exercise Price
|
A-9
|
3.3
|
Dollar Limitation
|
A-9
|
3.4
|
10% Stockholder
|
A-9
|
3.5
|
Incentive Stock Options Not Transferable
|
A-9
|
3.6
|
Compliance with Section 422 of the Code
|
A-9
|
3.7
|
Limitations on Exercise
|
A-9
|
3.8
|
Notification of Disqualifying Disposition
|
A-9
|
3.9
|
Option Repricing Prohibited
|
A-9
|
|
ARTICLE IV. STOCK APPRECIATION RIGHTS
|
|
4.1
|
Eligibility
|
A-10
|
4.2
|
Grant Price
|
A-10
|
4.3
|
Terms
|
A-10
|
4.4
|
Payment of Stock Appreciation Rights
|
A-10
|
4.5
|
Repricing Prohibited
|
A-10
|
|
ARTICLE V. PHANTOM STOCK
|
|
5.1
|
Eligibility and Awards
|
A-10
|
5.2
|
Terms
|
A-10
|
5.3
|
Lapse of Restrictions/Payment
|
A-10
|
5.4
|
Performance Goals
|
A-10
|
|
ARTICLE VI. RESTRICTED STOCK
|
|
6.1
|
Eligibility
|
A-10
|
6.2
|
Terms
|
A-11
|
6.3
|
Restrictions, Restricted Period and Vesting
|
A-11
|
6.4
|
Delivery of Shares of Common Stock
|
A-11
|
6.5
|
Performance Goals
|
A-11
|
|
|
|
|
ARTICLE VII. RESTRICTED STOCK UNITS
|
|
7.1
|
Eligibility and Awards
|
A-11
|
7.2
|
Terms
|
A-12
|
7.3
|
Payment/Settlement of Restricted Stock Units
|
A-12
|
7.4
|
Performance Goals
|
A-12
|
|
ARTICLE VIII. OTHER STOCK OR PERFORMANCE-BASED AWARDS
|
A-12
|
|
ARTICLE IX. PERFORMANCE-BASED COMPENSATION
|
|
9.1
|
Awards of Performance-Based Compensation
|
A-12
|
9.2
|
Performance Goals
|
A-12
|
|
ARTICLE X. CERTAIN PROVISIONS APPLICABLE TO ALL AWARDS
|
|
10.1
|
General
|
A-14
|
10.2
|
Stand-Alone, Additional and Tandem Awards
|
A-14
|
10.3
|
Term of Awards
|
A-14
|
10.4
|
Securities Requirements
|
A-14
|
10.5
|
Transferability
|
A-14
|
10.6
|
No Rights as a Stockholder
|
A-14
|
10.7
|
Listing and Registration of Shares of Common Stock
|
A-15
|
10.8
|
Termination
|
A-15
|
10.9
|
Change of Control
|
A-15
|
10.10
|
Payment or Settlement of Awards
|
A-16
|
10.11
|
Lock-Up Agreement
|
A-16
|
10.12
|
Stockholder Agreements/Investment Representations
|
A-16
|
10.13
|
Exemptions from Section 16(b) Liability
|
A-16
|
|
ARTICLE XI. WITHHOLDING FOR TAXES
|
A-16
|
|
ARTICLE XII. MISCELLANEOUS
|
|
12.1
|
No Rights to Awards or Uniformity Among Awards
|
A-16
|
12.2
|
Conflicts with Plan
|
A-16
|
12.3
|
Rights as Employee, Service Provider or Director
|
A-17
|
12.4
|
Governing Law
|
A-17
|
12.5
|
Gender, Tense and Headings
|
A-17
|
12.6
|
Severability
|
A-17
|
12.7
|
Other Laws
|
A-17
|
12.8
|
Unfunded Obligations
|
A-17
|
12.9
|
No Guarantee of Tax Consequences
|
A-17
|
12.10
|
Stockholder Agreements
|
A-17
|
12.11
|
Specified Employee under Section 409A of the Code
|
A-17
|
12.12
|
No Additional Deferral Features
|
A-17
|
12.13
|
Compliance with Section 409A of the Code
|
A-18
|
12.14
|
Claw-back Policy
|
A-18
|
i.
|
stock price;
|
ii.
|
earnings per share;
|
iii.
|
increase in revenues;
|
iv.
|
increase in cash flow;
|
v.
|
cash flow per share;
|
vi.
|
increase in cash flow return;
|
vii.
|
return on net assets;
|
viii.
|
return on assets;
|
ix.
|
return on investment;
|
x.
|
return on capital;
|
xi.
|
return on equity;
|
xii.
|
economic value added;
|
xiii.
|
gross margin;
|
xiv.
|
net income;
|
xv.
|
pretax earnings;
|
xvi.
|
pretax earnings before interest;
|
xvii.
|
pretax earnings before interest, depreciation and amortization;
|
xviii.
|
pretax operating earnings after interest expense and before incentives, service fees and extraordinary or special items;
|
xix.
|
operating income;
|
xx.
|
total stockholder return;
|
xxi.
|
debt reduction;
|
xxii.
|
successful completion of an acquisition, initial public offering, private placement of equity or debt; or
|
xxiii.
|
reduction of expenses.
|
|
|
|
|
n
|
|
|
n
|
¢
20630300000000000000 0
|
|
|
|
042216
|
|
|
|
|
FOR
|
|
AGAINST
|
|
ABSTAIN
|
PROPOSAL 1:
|
|
Election of the seven directors to serve until next annual meeting of stockholders of the Company or until their successors are duly elected and qualified, or until their earlier resignation or removal.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ted D. Brown
|
|
¨
|
|
¨
|
|
¨
|
|
|
John W. Chisholm
|
|
¨
|
|
¨
|
|
¨
|
|
|
L. Melvin Cooper
|
|
¨
|
|
¨
|
|
¨
|
|
|
Carla S. Hardy
|
|
¨
|
|
¨
|
|
¨
|
|
|
Kenneth T. Hern
|
|
¨
|
|
¨
|
|
¨
|
|
|
L.V. “Bud” McGuire
|
|
¨
|
|
¨
|
|
¨
|
|
|
John S. Reiland
|
|
¨
|
|
¨
|
|
¨
|
|
|
|
|
|
|
|
|
|
PROPOSAL 2:
|
|
Approval of the Amended and Restated Flotek Industries, Inc. 2014 Long-Term Incentive Plan.
|
|
¨
|
|
¨
|
|
¨
|
|
|
|
|
|
|
|
|
|
PROPOSAL 3:
|
|
Approval of Non-Binding Advisory Vote on Executive Compensation.
|
|
¨
|
|
¨
|
|
¨
|
|
|
|
|
|
|
|
|
|
PROPOSAL 4:
|
|
Ratification of the selection of the independent registered public accounting firm, HEIN & ASSOCIATES LLP, as the Company’s auditors for the year ending December 31, 2016.
|
|
¨
|
|
¨
|
|
¨
|
Signature of Stockholder
|
|
|
|
Date:
|
|
|
|
Signature of Stockholder
|
|
|
|
Date:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Note:
|
Please sign exactly as your name or names appear on this Proxy. When shares are held jointly, each holder should sign. When signing as executor, administrator, attorney, trustee or guardian, please give full title as such. If the signer is a corporation, please sign full corporate name by duly authorized officer, giving full title as such. If signer is a partnership, please sign in partnership name by authorized person.
|
|
||
|
|
|
|
|
|
|
|||||
To change the address on your account, please check the box at right and indicate your new address in the address space above. Please note that changes to the registered name(s) on the account may not be submitted via this method.
|
|
¨
|
n
|
|
n
|
|
|
PROXY VOTING INSTRUCTIONS
|
|
|
TELEPHONE - Call toll-free 1-800-PROXIES (1-800-776-9437) in the United States or 1-718-921-8500 from foreign countries from any touch-tone telephone and follow the instructions. Have your proxy card available when you call.
Vote online/phone until 11:59 PM EST the day before the meeting.
|
|
|
|
|
COMPANY NUMBER
|
|
|
MAIL - Sign, date and mail your proxy card in the envelope provided as soon as possible.
|
|
ACCOUNT NUMBER
|
|
IN PERSON - You may vote your shares in person by attending the Annual Meeting.
|
|
|
|
NOTICE OF INTERNET AVAILABILITY OF PROXY MATERIAL
:
The Notice of Meeting, proxy statement and proxy card
are available at www.flotekind.com/proxymaterials.
|
i
Please detach along perforated line and mail in the envelope provided
IF
you are not voting via telephone or the Internet.
i
|
¢
20630300000000000000 0
|
|
|
|
042216
|
|
|
|
|
FOR
|
|
AGAINST
|
|
ABSTAIN
|
PROPOSAL 1:
|
|
Election of the seven directors to serve until next annual meeting of stockholders of the Company or until their successors are duly elected and qualified, or until their earlier resignation or removal.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ted D. Brown
|
|
¨
|
|
¨
|
|
¨
|
|
|
John W. Chisholm
|
|
¨
|
|
¨
|
|
¨
|
|
|
L. Melvin Cooper
|
|
¨
|
|
¨
|
|
¨
|
|
|
Carla S. Hardy
|
|
¨
|
|
¨
|
|
¨
|
|
|
Kenneth T. Hern
|
|
¨
|
|
¨
|
|
¨
|
|
|
L.V. “Bud” McGuire
|
|
¨
|
|
¨
|
|
¨
|
|
|
John S. Reiland
|
|
¨
|
|
¨
|
|
¨
|
|
|
|
|
|
|
|
|
|
PROPOSAL 2:
|
|
Approval of the Amended and Restated Flotek Industries, Inc. 2014 Long-Term Incentive Plan.
|
|
¨
|
|
¨
|
|
¨
|
|
|
|
|
|
|
|
|
|
PROPOSAL 3:
|
|
Approval of Non-Binding Advisory Vote on Executive Compensation.
|
|
¨
|
|
¨
|
|
¨
|
|
|
|
|
|
|
|
|
|
PROPOSAL 4:
|
|
Ratification of the selection of the independent registered public accounting firm, HEIN & ASSOCIATES LLP, as the Company’s auditors for the year ending December 31, 2016.
|
|
¨
|
|
¨
|
|
¨
|
Signature of Stockholder
|
|
|
|
Date:
|
|
|
|
Signature of Stockholder
|
|
|
|
Date:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Note:
|
Please sign exactly as your name or names appear on this Proxy. When shares are held jointly, each holder should sign. When signing as executor, administrator, attorney, trustee or guardian, please give full title as such. If the signer is a corporation, please sign full corporate name by duly authorized officer, giving full title as such. If signer is a partnership, please sign in partnership name by authorized person.
|
|
||
|
|
|
|
|
|
|
|||||
To change the address on your account, please check the box at right and indicate your new address in the address space above. Please note that changes to the registered name(s) on the account may not be submitted via this method.
|
|
¨
|
|||
|
|
|
|
|
|
n
|
|
|
|
|
n
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|
No information found
Customers
Customer name | Ticker |
---|---|
International Flavors & Fragrances Inc. | IFF |
No Suppliers Found
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|